Table 1 Baseline sample characteristics and measure scores of the treatment groups

Female (n (%))

8 (50)

13 (76.5)

X² = 2.496

.114

Age (M (SD))

39.1 (14.1)

45.1 (14.7)

t = -1.17

.251

Comorbidity (n (%))

11 (68.8)

6 (35.3)

X² = 3.694

.055

Anxiety disorders (n (%))

4 (25)

2(11.8)

Personality disorders (n (%))

3(18.8)

3(17.6)

Measures

 HDRS-21 (M(SD))

31.31 (5.1)

28.12 (6.5)

t = 1.56

.129

 BDI-II (M(SD))

32.81 (10.2)

30.82 (10.4)

t = .556

.582

daily steps (M(SD))

9449 (3786)

7182 (2851)

t = 1.807

.081